Journal Information
Special article
Simulator of interactions of the human immune system: Description of the model for the life cycle of human papillomavirus type 16 and therapeutic vaccines
M.E. Escobar Ospina
Vacunas. 2022;23:1-16
Originals
Cost-minimization and opportunity cost analysis of fully-liquid hexavalent and meningococcal vaccines in Spain
Inmaculada Cuesta, David Carcedo, María José Menor, Georgina Drago, Escolano Manuel, Juan Luis López-Belmonte, Sonia López, Hosanna Parra, ... Sonia Tamames
Vacunas. 2022;23:17-26
Compliance to vaccination recommendations in people living with human immunodeficiency virus: Cross sectional study
Irene Cavada Carranza, Javier Sánchez-Rubio Ferrández, Gabriel Gaspar Alonso Vega, Teresa Molina García
Vacunas. 2022;23:27-31
Impact of the 13-valent conjugate pneumococcal vaccine on the incidence of invasive pneumococcal disease in Catalonia: Retrospective study, 2014–2015 vs. 2017–2018
S. Broner, C. Izquierdo, M.M. Nogueras, S. Hernández, C. Muñoz-Almagro, R. Pallarés, M. Jané, P. Ciruela
Vacunas. 2022;23:32-41
Seroprevalence of measles antibodies among health professionals of Estonia
A. Tisler, N. Nikitina, E. Yusuf
Vacunas. 2022;23:42-5
Review article
The role of “original antigenic sin” on influenza vaccine response
Jordi Reina, Carla Iglesias
Vacunas. 2022;23:46-54
Diagnosis of COVID-19 in symptomatic patients: An updated review
M.N. Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, S.A. Ahmadi, N.S. Juyena, M.T. Rahman, M.S. Parvej
Vacunas. 2022;23:55-61
Special article
Special Article
Letter to the editor
Role of community pharmacies in the prevention of communicable diseases
Pere Plans Rubió
Vacunas. 2022;23:62-3